10th week of 2019 patent applcation highlights part 7 |
Patent application number | Title | Published |
20190070070 | SPA BATH WITH HEAT PUMP | 2019-03-07 |
20190070071 | IMPRINTED MEDICAL PACKAGES AND METHODS OF MAKING AND USING THE SAME | 2019-03-07 |
20190070072 | MULTILAYER VESSEL, AND APPLICATION THEREOF | 2019-03-07 |
20190070073 | MIXING APPARATUS AND METHOD THEREOF | 2019-03-07 |
20190070074 | METHOD FOR PRODUCING A MEDICAL PREPARATION | 2019-03-07 |
20190070075 | Systems, Devices, and/or Methods for Managing Medicament Dispenser | 2019-03-07 |
20190070076 | WET SHEET PACKAGE | 2019-03-07 |
20190070077 | COSMETIC | 2019-03-07 |
20190070078 | TRUFFLE CONFIGURED COSMETIC ARTICLE | 2019-03-07 |
20190070079 | PHYSICAL SOLAR FILTER CONSISTING OF SUBSTITUTED HYDROXYAPATITE IN AN ORGANIC MATRIX | 2019-03-07 |
20190070080 | Artificial Saliva | 2019-03-07 |
20190070081 | DEODORIZING COSMETIC COMPOSITION AND METHOD FOR PREPARING SAME | 2019-03-07 |
20190070082 | OXIDATIVE COLORATION OF HAIR WITH REDUCED HAIR DAMAGE | 2019-03-07 |
20190070083 | HAIR TREATMENT AGENT WITH A POLYVALENT METAL CATION I | 2019-03-07 |
20190070084 | HAIR TREATMENT AGENT WITH A POLYVALENT CATION II | 2019-03-07 |
20190070085 | ALIPHATIC ANIONIC COMPOUNDS AND OXIDATIVE COMPOUNDS WITH IMPROVED STABILITY AND EFFICACY FOR USE IN PHARMACEUTICAL COMPOSITIONS | 2019-03-07 |
20190070086 | FRAGRANCE MATERIALS | 2019-03-07 |
20190070087 | HAIR TREATMENT COMPOSITIONS | 2019-03-07 |
20190070088 | SILK PROTEIN FRAGMENT COMPOSITIONS AND ARTICLES MANUFACTURED THEREFROM | 2019-03-07 |
20190070089 | Stable Silk Protein Fragment Compositions | 2019-03-07 |
20190070090 | WATER-BASED COSMETIC AND MANUFACTURING METHOD THEREOF | 2019-03-07 |
20190070091 | PROPELLANT-CONTAINING COSMETIC PREPARATIONS WITH STARCH PARTICLES AND ANIONIC POLYMER | 2019-03-07 |
20190070092 | FOAMING AGENT-CONTAINING COSMETIC COMPOSITIONS HAVING PIGMENT-CONTAINING STARCH PARTICULATES AND ANIONIC POLYMER | 2019-03-07 |
20190070093 | COSMETIC AGENT FORMED BY GALACTOMANNANS OBTAINED FROM CAESALPINIA SPINOSA AND CROSS-LINKED SULPHATED GALACTANS OBTAINED FROM KAPPAPHYCUS ALVAREZII | 2019-03-07 |
20190070094 | COMPOSITION COMPRISING A POLYSACCHARIDE ALKYL ETHER AND INCOMPATIBLE OILS AND METHOD EMPLOYING IT | 2019-03-07 |
20190070095 | HAIR CARE COMPOSITIONS | 2019-03-07 |
20190070096 | FOLLOWER COMPOSITION FOR COSMETIC APPLICATOR | 2019-03-07 |
20190070097 | NAIL COMPOSITION | 2019-03-07 |
20190070098 | COSMETIC COMPOSITION AND PREPARATION METHOD | 2019-03-07 |
20190070099 | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME | 2019-03-07 |
20190070100 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | 2019-03-07 |
20190070101 | Pharmaceutical Compositions Comprising Flurbiprofen | 2019-03-07 |
20190070102 | SPRAYABLE POLYMERS AS ADHESION BARRIERS | 2019-03-07 |
20190070103 | METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES AND CLUSTER HEADACHES | 2019-03-07 |
20190070104 | VAGINAL RING WITH VISUAL INDICATION OF USE | 2019-03-07 |
20190070105 | LIQUID NALOXONE SPRAY | 2019-03-07 |
20190070106 | OPHTHALMIC PREPARATIONS | 2019-03-07 |
20190070107 | RESIDENCE STRUCTURES AND RELATED METHODS | 2019-03-07 |
20190070108 | RESIDENCE STRUCTURES AND RELATED METHODS | 2019-03-07 |
20190070109 | PHARMACEUTICAL COMPOSITION FOR ORAL DELIVERY | 2019-03-07 |
20190070110 | PARENTERAL DOSAGE FORM OF AMIODARONE | 2019-03-07 |
20190070111 | POMEGRANATE OIL FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES | 2019-03-07 |
20190070112 | METHOD OF LYOPHILIZING LIPOSOMES | 2019-03-07 |
20190070113 | Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted Docetaxel-Generating Nano-Liposome Compositions | 2019-03-07 |
20190070114 | Liposome Containing Compositions and Their Use in Personal Care and Food Products | 2019-03-07 |
20190070115 | Compositions and Methods for On-Demand High-Efficiency Triggerable Anesthesia | 2019-03-07 |
20190070116 | Dry Acid Concentrate In Granulate Form | 2019-03-07 |
20190070117 | Novel Method for Vacuum-Assisted Preservation of Biologics Including Vaccines | 2019-03-07 |
20190070118 | COMPOSITIONS AND METHODS FOR DELIVERY OF OMEPRAZOLE PLUS ACETYLSALICYLIC ACID | 2019-03-07 |
20190070119 | Pharmaceutical Formulation Containing Gelling Agent | 2019-03-07 |
20190070120 | Pharmaceutical Composition Comprising Canagliflozin, Process of Preparation and Use Thereof | 2019-03-07 |
20190070121 | Controlled Release Dosage Form with Enhanced Pharmacokinetics | 2019-03-07 |
20190070122 | TRANSDERMAL ABSORPTION-TYPE PATCH PREPARATION COMPRISING ZONISAMIDE | 2019-03-07 |
20190070123 | TRANSDERMAL PREPARATION | 2019-03-07 |
20190070124 | COMPOSITIONS OF CB2 RECEPTOR SELECTIVE AGONISTS FOR TREATMENT OF MENTAL DISORDERS | 2019-03-07 |
20190070125 | SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS | 2019-03-07 |
20190070126 | METHOD FOR SUPPORTING MEMORY FUNCTION AND/OR COGNITIVE FUNCTION | 2019-03-07 |
20190070127 | COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS | 2019-03-07 |
20190070128 | USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA | 2019-03-07 |
20190070129 | COMPOSITION COMPRISING PANDURATIN OR FINGERROOT (BOESENBERGIA PANDURATA) EXTRACT FOR TREATING, PREVENTING, OR AMELIORATING BONE LOSS DISEASE | 2019-03-07 |
20190070130 | COMPOSITIONS AND METHODS USING A POLYPHENOL FOR MUSCULOSKELETAL HEALTH | 2019-03-07 |
20190070131 | Sublingual Epinephrine Tablets | 2019-03-07 |
20190070132 | COMPOSITIONS FOR CONTROLLED RELEASE OF CYSTEAMINE AND SYSTEMIC TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | 2019-03-07 |
20190070133 | PHARMACEUTICAL COMPOSITION FOR IMPROVING OR PREVENTING PROGRESSION OF CHRONIC KIDNEY DISEASE | 2019-03-07 |
20190070134 | NASAL FORMULATIONS OF METOCLOPRAMIDE | 2019-03-07 |
20190070135 | Artificial Saliva | 2019-03-07 |
20190070136 | PARENTERAL COMPOSITIONS OF CARMUSTINE | 2019-03-07 |
20190070137 | Solid Solution Compositions and Use in Chronic Inflammation | 2019-03-07 |
20190070138 | SOLID DOSAGE FORMS OF VIGABATRIN | 2019-03-07 |
20190070139 | AGENT FOR IMPROVING PHYSICAL FITNESS | 2019-03-07 |
20190070140 | COMPOSITION COMPRISING PROTECTIN DX AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR FATTY LIVER DISEASE | 2019-03-07 |
20190070141 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2019-03-07 |
20190070142 | TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES | 2019-03-07 |
20190070143 | DIMETHYL FUMARATE PARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2019-03-07 |
20190070144 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2019-03-07 |
20190070145 | USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS | 2019-03-07 |
20190070146 | SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV | 2019-03-07 |
20190070147 | ENALAPRIL FORMULATIONS | 2019-03-07 |
20190070148 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders | 2019-03-07 |
20190070149 | PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 2019-03-07 |
20190070150 | METHOD FOR TREATING HEPATIC ENCEPHALOPATHY | 2019-03-07 |
20190070151 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2019-03-07 |
20190070152 | DE-EPOXIDIZED EPOTHILONE DERIVATIVE PREPARATION, PREPARATION OF SAME AND USE THEREOF IN THE TREATMENT OF TUMOUR | 2019-03-07 |
20190070153 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISEASES | 2019-03-07 |
20190070154 | NEW METHODS OF USE FOR AN ANTI-DIARRHEA AGENT | 2019-03-07 |
20190070155 | PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF | 2019-03-07 |
20190070156 | Treatment of Debilitating Fatigue | 2019-03-07 |
20190070157 | HYPERBARIC SOLUTION INJECTION OF LEVOBUPIVACAINE HYDROCHLORIDE COMPRISING LEVOBUPIVACAINE HYDROCHLORIDE | 2019-03-07 |
20190070158 | VETERINARY COMPOSITION COMPRISING IMIDACLOPRID, MOXIDECTIN AND PRAZIQUANTEL FOR CUTANEOUS TOPICAL APPLICATION (SPOT ON), FOR THE TREATMENT AND PREVENTION OF ECTO AND ENDOPARASITOSES AFFECTING DOGS | 2019-03-07 |
20190070159 | NOVEL PHARMACEUTICAL USES | 2019-03-07 |
20190070160 | COMPOSITIONS AND METHODS OF TREATING DERMAL FIBROTIC DISORDERS | 2019-03-07 |
20190070161 | FORMULATIONS FOR CGRP RECEPTOR ANTAGONISTS | 2019-03-07 |
20190070162 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE- -3-CARBOXAMIDE | 2019-03-07 |
20190070163 | ANTITUMOR AGENT | 2019-03-07 |
20190070164 | CONTROLLED RELEASE COMPOSITIONS FOR TREATMENT OF COGNITIVE, EMOTIONAL, AND MENTAL AILMENTS AND DISORDERS | 2019-03-07 |
20190070165 | N-HYDROXYISOQUINOLINEDIONE INHIBITORS OF HBV REPLICATION | 2019-03-07 |
20190070166 | Optimized Method for Treating and Curing Arthritis, Diabetes, Multiple Sclerosis and Other Autoimmune Disease | 2019-03-07 |
20190070167 | PITAVASTATIN CONTAINING PREPARATION AND METHOD FOR PRODUCING SAME | 2019-03-07 |
20190070168 | GAP JUNCTION-ENHANCING AGENTS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS AND INFLAMMATORY BOWEL DISEASE | 2019-03-07 |
20190070169 | TREATMENT OF CANCER | 2019-03-07 |